wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38125609-D33FC04F-14E2-411F-AF79-6A55314BDE27
Q38125609-D33FC04F-14E2-411F-AF79-6A55314BDE27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38125609-D33FC04F-14E2-411F-AF79-6A55314BDE27
Clinical experience with Zarzio® in Europe: what have we learned?
P2860
Q38125609-D33FC04F-14E2-411F-AF79-6A55314BDE27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38125609-D33FC04F-14E2-411F-AF79-6A55314BDE27
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b83d42154c662460af576b7124df0b6678104834
P2860
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.